BlackRock Institutional Trust’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

BlackRock Institutional Trust’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$441K	Hold	1,998	–	–	﹤0.01%	3484
2016 Q3	$480K	Buy	1,998 +1,911	+2,197%	+$397K	﹤0.01%	3491
2016 Q2	$17K	Hold	87	–	–	﹤0.01%	3835
2016 Q1	$37K	Hold	87	–	–	﹤0.01%	3815
2015 Q4	$33K	Sell	87 -12	-12%	-$3.76K	﹤0.01%	3842
2015 Q3	$27K	Hold	99	–	–	﹤0.01%	3868
2015 Q2	$29K	Sell	99 -180	-65%	-$54.4K	﹤0.01%	3820
2015 Q1	$77K	Sell	279 -659	-70%	-$285K	﹤0.01%	3723
2014 Q4	$405K	Buy	938 +12	+1%	+$3.81K	﹤0.01%	3535
2014 Q3	$303K	Buy	926 +279	+43%	+$81.8K	﹤0.01%	3564
2014 Q2	$218K	Buy	647 +310	+92%	+$122K	﹤0.01%	3693
2014 Q1	$150K	Buy	+337	New	+$153K	﹤0.01%	3732

Other funds holding DMK

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SGS

Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Institutional Trust's DMK Position: Q4 2016 in Review

BlackRock Institutional Trust held its DMK Pharmaceuticals Corporation Common Stock (DMK) position steady in Q4 2016 at 1,998 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #3484.

BlackRock Institutional Trust first reported a position in DMK in Q1 2014 and has held it in 12 quarters since. The position peaked at $480K in Q3 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

BlackRock Institutional Trust held 1,998 shares of DMK Pharmaceuticals Corporation Common Stock worth $441K as of Q4 2016.
BlackRock Institutional Trust left its DMK Pharmaceuticals Corporation Common Stock share count unchanged in Q4 2016.
DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3484 holding.
BlackRock Institutional Trust first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and has held it in 12 quarters since.
BlackRock Institutional Trust's DMK Pharmaceuticals Corporation Common Stock position peaked at $480K in Q3 2016.
35 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.